NICXF
Price:
$0.3
Market Cap:
$29.29M
Nicox S.A. is an international ophthalmic pharmaceutical company, headquartered in Valbonne, France, and established in 1996. Its core mission is to develop innovative treatments aimed at preserving sight and enhancing overall eye health. The company's primary investigational compound, NCX 470, a cutting-edge nitric oxide-donating prostaglandin analog, is currently undergoing Phase 3 clinical trials. This candidate is designed to reduce elevated intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. Additionally, Nicox is advancing NCX 4251, a unique fluticasone formulation in Phase 2b clinical trials, specifically targeting severe flare-ups of blephar...[Read more]
Industry
Biotechnology
IPO Date
2010-02-22
Stock Exchange
OTC
Ticker
NICXF
According to Nicox S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.79. This represents a change of 1.10% compared to the average of -0.07 of the last 4 quarters.
The mean historical PE Ratio of Nicox S.A. over the last ten years is -4.63. The current -0.79 PE Ratio has changed 1.60% with respect to the historical average. Over the past ten years (40 quarters), NICXF's PE Ratio was at its highest in in the June 2024 quarter at 0. The PE Ratio was at its lowest in in the December 2022 quarter at -2330.04.
Average
-4.63
Median
-2.19
Minimum
-10.88
Maximum
-0.63
Discovering the peaks and valleys of Nicox S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.64%
Maximum Annual PE Ratio = -0.63
Minimum Annual Increase = -72.94%
Minimum Annual PE Ratio = -10.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.88 | 1.64% |
| 2024 | -0.63 | -40.51% |
| 2023 | -1.05 | -41.36% |
| 2022 | -1.79 | -18.21% |
| 2021 | -2.19 | -72.94% |
| 2020 | -8.10 | 4.31% |
The current PE Ratio of Nicox S.A. (NICXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.19
5-year avg
-3.31
10-year avg
-4.63
Nicox S.A.’s PE Ratio is greater than Alterity Therapeutics Limited (-8.02), greater than Calliditas Therapeutics Ab (-23.95), greater than BioStem Technologies, Inc. (-3.52), greater than IXICO plc (-4.23), greater than Actinogen Medical Limited (-5.69), less than MindMaze Therapeutics Holding S.A. Sponsored ADR (0), less than MindMaze Therapeutics Holding S.A. (0), less than Planet 13 Holdings Inc. (-0.59), greater than Helix BioPharma Corp. (-34.48), less than Imugene Limited (-0.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.02 | $11.96M | |
| -23.95 | $19.80M | |
| -3.52 | $70.55M | |
| -4.23 | $6.51M | |
| -5.69 | $2.87M | |
| 0 | $5.30M | |
| 0 | $4.22M | |
| -0.59 | $41.40M | |
| -34.48 | $130.61M | |
| -0.49 | $35.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nicox S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nicox S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nicox S.A.'s PE Ratio?
How is the PE Ratio calculated for Nicox S.A. (NICXF)?
What is the highest PE Ratio for Nicox S.A. (NICXF)?
What is the 3-year average PE Ratio for Nicox S.A. (NICXF)?
What is the 5-year average PE Ratio for Nicox S.A. (NICXF)?
How does the current PE Ratio for Nicox S.A. (NICXF) compare to its historical average?